Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Ellerby

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Brain Research|December 21, 2023
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegenerationFadzai Teramayi, Joanna Bons, Madeleine Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 IsoformsMaria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Molecular & Cellular Proteomics : MCP|June 21, 2011
Mass spectrometric identification of novel lysine acetylation sites in huntingtinXin Cong, Jason M Held, Francesco DeGiacomo, et al.
Human Molecular Genetics|April 11, 2015
Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunctionStephan J Guyenet, Shona S Mookerjee, Amy Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2005
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's diseaseKunlin Jin, Michelle LaFevre-Bernt, Yunjuan Sun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Archives of Biochemistry and Biophysics|January 27, 2025
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenaseKaylen R Meeks, Juan Ji, Gary K Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2006
Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemiaAdil A Khan, Yaoming Wang, Yunjuan Sun, et al.
The Journal of Biological Chemistry|May 17, 2003
An artificially designed pore-forming protein with anti-tumor effectsH Michael Ellerby, Sannamu Lee, Lisa M Ellerby, et al.
FEBS Letters|April 12, 2002
Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78Rammohan V Rao, Alyson Peel, Anna Logvinova, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Brain Research|December 21, 2023
Brain transcriptomic, metabolic and mitohormesis properties associated with N-propargylglycine treatment: A prevention strategy against neurodegenerationFadzai Teramayi, Joanna Bons, Madeleine Scott, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 IsoformsMaria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Molecular & Cellular Proteomics : MCP|June 21, 2011
Mass spectrometric identification of novel lysine acetylation sites in huntingtinXin Cong, Jason M Held, Francesco DeGiacomo, et al.
Human Molecular Genetics|April 11, 2015
Proteolytic cleavage of ataxin-7 promotes SCA7 retinal degeneration and neurological dysfunctionStephan J Guyenet, Shona S Mookerjee, Amy Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2005
FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington's diseaseKunlin Jin, Michelle LaFevre-Bernt, Yunjuan Sun, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 18, 2025
Twenty years of therapeutic development in tauopathy mouse models: a scoping reviewVanessa F Langness, Danielle A Simmons, Tyne L M McHugh, et al.
Archives of Biochemistry and Biophysics|January 27, 2025
Biochemical, structural, and cellular characterization of S-but-3-yn-2-ylglycine as a mechanism-based covalent inactivator of the flavoenzyme proline dehydrogenaseKaylen R Meeks, Juan Ji, Gary K Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2006
Neuroglobin-overexpressing transgenic mice are resistant to cerebral and myocardial ischemiaAdil A Khan, Yaoming Wang, Yunjuan Sun, et al.
The Journal of Biological Chemistry|May 17, 2003
An artificially designed pore-forming protein with anti-tumor effectsH Michael Ellerby, Sannamu Lee, Lisa M Ellerby, et al.
FEBS Letters|April 12, 2002
Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78Rammohan V Rao, Alyson Peel, Anna Logvinova, et al.
Pageof 10